Summary & Overview
HCPCS Q4332: Axolotl Dualgraft, Per Square Centimeter
HCPCS Level II code Q4332 designates an Axolotl dualgraft product billed per square centimeter as an add-on to a primary procedure. As a product-level add-on code, Q4332 matters nationally for surgical and wound-care billing because it captures incremental charges for biologic graft materials that augment primary reconstructive or wound repair procedures. Accurate use of this code affects facility and professional claims where graft materials are supplied and billed separately from the primary procedure.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find context on clinical use cases for dualgraft products, typical sites of service where the material is applied, and the operational implications of add-on, per-unit billing for graft products. The publication provides benchmarks for coding and billing practice, highlights payer coverage considerations, and outlines the clinical scenarios driving utilization of per-square-centimeter graft billing.
This resource is intended for national audiences including coding professionals, billing staff, and clinical administrators who manage supply charges and procedure add-ons for wound care and reconstructive services. Data not available in the input will be noted where applicable.
Billing Code Overview
HCPCS Level II code Q4332 describes an Axolotl dualgraft billed per square centimeter as an add-on, list separately in addition to primary procedure. This code represents a grafting product or material used in wound care or reconstructive procedures where dualgraft application is performed and measured by surface area.
Service type: Graft product/material for surgical wound or reconstructive procedures
Typical site of service: Operative/surgical settings, hospital outpatient departments, ambulatory surgery centers, and specialized wound care clinics
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric individual with a full-thickness or complex partial-thickness skin defect (for example, traumatic loss of dermis and epidermis, chronic non-healing wound after excision of scar tissue, or reconstructive needs after tumor resection) requiring advanced biologic skin substitute therapy. The encounter occurs in an outpatient ambulatory surgical center or hospital outpatient department where a primary reconstructive procedure (such as debridement, excision, or placement of a primary skin graft) is performed and the clinician elects to apply an adjunctive cultured or engineered dermal product billed as an add-on per square centimeter.
Clinical workflow:
-
The patient is evaluated by a plastic surgeon, dermatologic surgeon, or wound care specialist who documents wound size, depth, prior treatments, and clinical indication for adjunctive biologic grafting.
-
Pre-procedure planning includes measurement and photography of the wound, informed consent, and selection of the Axolotl dualgraft product with calculation of square centimeters required.
-
In the procedure suite, the primary procedure (for example, debridement or autologous graft placement) is performed first. The Axolotl dualgraft product is then prepared and applied to the wound bed to augment healing; product area used is recorded in square centimeters for billing.
-
Post-procedure documentation includes product lot number, area applied (
cm2), wound dressing instructions, and plan for follow-up wound checks. The add-on HCPCS Level II codeQ4332is billed in addition to the primary procedure code to reflect the per-square-centimeter application of the Axolotl dualgraft.